신장 결석 관리 시장 : 시장 규모, 점유율 및 성장률, 산업 분석 - 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of kidney stone management Market

The global kidney stone management market size was valued at USD 1.98 billion in 2025. The market is projected to grow to USD 2.09 billion in 2026 and further reach USD 3.37 billion by 2034, reflecting steady expansion driven by increasing disease prevalence and rising adoption of minimally invasive treatment procedures. North America dominated the kidney stone management market with a 36.03% market share in 2025, supported by advanced healthcare infrastructure, higher diagnosis rates, and strong availability of technologically advanced medical devices.

Kidney stone disease, also known as nephrolithiasis, affects a significant portion of the adult population, with recurrence rates exceeding 30% within ten years. The growing burden of obesity, diabetes, hypertension, and sedentary lifestyles is increasing the risk of stone formation, thereby driving sustained demand for kidney stone treatment devices across hospital and outpatient settings.

Market Drivers and Growth Factors

The increasing preference for minimally invasive surgical techniques is one of the strongest drivers of the kidney stone management market. Procedures such as ureteroscopic lithotripsy, extracorporeal shock wave lithotripsy, and percutaneous nephrolithotomy are widely adopted due to reduced post-operative pain, lower complication rates, shorter hospital stays, and quicker recovery times. Surgeons are shifting away from open surgeries, leading to higher procedural volumes and greater device utilization.

Technological advancements in flexible fiber-optic ureteroscopes, digital imaging systems, and laser lithotripsy platforms are improving procedural accuracy and clinical success rates. Innovations such as high-energy holmium laser systems allow efficient stone fragmentation with minimal damage to surrounding tissues, improving treatment outcomes and driving hospital investment in advanced urology equipment.

Market Restraints and Challenges

Despite technological progress, certain treatment approaches present limitations. Shock wave lithotripsy is associated with risks such as renal tissue damage, bleeding, urinary obstruction, and possible increases in arterial blood pressure. These side effects can restrict patient eligibility and physician preference in certain cases, limiting broader adoption in complex stone conditions.

Cost barriers also affect adoption in developing regions, where healthcare budgets remain constrained and access to advanced surgical devices is limited. In addition, lack of specialized urology infrastructure in rural healthcare facilities reduces procedural availability, particularly in emerging economies.

Impact of COVID-19 on the Market

The COVID-19 pandemic caused temporary disruption to kidney stone management services. Elective urology procedures were postponed, diagnostic visits declined, and healthcare resources were redirected toward emergency and infectious disease management. Medical device manufacturing and global supply chains also experienced slowdowns, resulting in delayed equipment procurement. Although demand recovered post-pandemic, procedural backlogs created short-term fluctuations in device utilization across hospitals and ambulatory surgical centers.

Segmentation Analysis

By Type

The market is segmented into lithotripsy, ureteroscopy, and percutaneous nephrolithotomy (PCNL). Among these, the ureteroscopy segment dominated with a 51.59% market share in 2026. This dominance is supported by high stone clearance rates, reduced recurrence risk, and strong suitability for both small and moderate-sized stones. Continuous improvements in scope flexibility, imaging clarity, and laser compatibility further strengthen adoption.

By End User

Based on end users, the market includes hospitals, specialty clinics, and ambulatory surgical centers. Hospitals accounted for the largest share at 55.89% in 2026, driven by higher patient volumes, access to full surgical facilities, and broader insurance coverage. Specialty clinics are gaining traction due to focused urology expertise, growing outpatient procedural capacity, and favorable reimbursement policies in selected countries.

Regional Market Insights

North America

North America recorded a market size of USD 0.71 billion in 2025, maintaining regional leadership due to strong diagnostic penetration, favorable reimbursement systems, and rapid technology adoption. The U.S. kidney stone management market is projected to reach USD 0.68 billion by 2026, supported by widespread use of minimally invasive procedures and high disease prevalence.

Europe

Europe holds the second-largest regional share, driven by rising incidence rates and increasing healthcare expenditures. By 2026, the Germany market is projected to reach USD 0.16 billion, while the UK market is projected to reach USD 0.07 billion, supported by high acceptance of advanced urology devices and structured referral systems within public healthcare networks.

Asia Pacific

Asia Pacific is expected to show strong expansion due to large patient populations and improving healthcare access. By 2026, the China market is projected to reach USD 0.14 billion, the Japan market USD 0.11 billion, and the India market USD 0.05 billion. Rising awareness, increasing hospital investments, and expanding private healthcare services are strengthening device demand across urban treatment centers.

Latin America and Middle East & Africa

These regions are experiencing gradual growth supported by improving healthcare infrastructure and increasing disease awareness. Expansion of hospital networks and international medical device partnerships is improving access to kidney stone management technologies.

Competitive Landscape and Industry Developments

The market is led by companies such as Boston Scientific Corporation, Olympus Corporation, KARL STORZ SE & Co. KG, Richard Wolf GmbH, Cook Medical, Lumenis, and EDAP TMS. These players maintain strong global presence through diversified product portfolios, continuous innovation, and strategic partnerships.

Key industry developments include the launch of advanced flexible ureteroscopic retrieval systems and high-energy laser platforms designed to improve procedural efficiency and safety. Expansion of laser lithotripsy technologies in emerging markets has further increased device penetration and competitive positioning among global manufacturers.

Report Coverage

The kidney stone management market report provides in-depth analysis of market size, segmentation by type and end user, regional performance, technology trends, competitive strategies, and recent product launches. The report evaluates growth factors, operational challenges, healthcare policy influences, and procedural adoption patterns shaping market development between 2025, 2026, and 2034, offering comprehensive insights for manufacturers, healthcare providers, investors, and strategic planners operating within the urology device industry.

Conclusion

The kidney stone management market is demonstrating steady and sustained expansion, with the global market valued at USD 1.98 billion in 2025, projected to reach USD 2.09 billion in 2026, and expected to grow further to USD 3.37 billion by 2034. This growth trajectory is strongly supported by the rising global prevalence of kidney stone disease, high recurrence rates, and increasing adoption of minimally invasive treatment procedures across healthcare systems.

Technological advancements in ureteroscopy, laser lithotripsy, and digital imaging platforms are significantly improving procedural success rates, reducing complications, and shortening recovery times, which is encouraging hospitals and specialty clinics to upgrade their urology equipment. The dominance of the ureteroscopy segment, holding 51.59% market share in 2026, and the strong position of hospitals with 55.89% share in 2026, highlight the continued preference for advanced, facility-based treatment options.

Segmentation By Type

• Lithotripsy
• Ureteroscopy
• Percutaneous Nephrolithonomy (PCNL)

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Geography

• North America (the U.S., and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• Middle East & Africa (South Africa, GCC, and the Rest of Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Reimbursement Scenario by Key Countries/Region
• 4.2. Recent Advancements in Kidney Stone Management Devices
• 4.3. Key Industry Trends
• 4.4. Key Industry Developments (Mergers, Acquisitions, and Partnerships)
• 4.5. Impact of COVID-19 on Kidney Stone Management Devices Market

5. Global Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Type
  • 5.2.1. Lithotripsy
  • 5.2.2. Ureteroscopy
  • 5.2.3. Percutaneous Nephrolithonomy (PCNL)
• 5.3. Market Analysis, Insights and Forecast - By End User
  • 5.3.1. Hospitals
  • 5.3.2. Specialty Clinics
  • 5.3.3. Ambulatory Surgical Centers
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis - By Type
  • 6.2.1. Lithotripsy
  • 6.2.2. Ureteroscopy
  • 6.2.3. Percutaneous Nephrolithonomy (PCNL)
• 6.3. Market Analysis - By End User
  • 6.3.1. Hospitals
  • 6.3.2. Specialty Clinics
  • 6.3.3. Ambulatory Surgical Centers
• 6.4. Market Analysis - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis - By Type
  • 7.2.1. Lithotripsy
  • 7.2.2. Ureteroscopy
  • 7.2.3. Percutaneous Nephrolithonomy (PCNL)
• 7.3. Market Analysis - By End User
  • 7.3.1. Hospitals
  • 7.3.2. Specialty Clinics
  • 7.3.3. Ambulatory Surgical Centers
• 7.4. Market Analysis - By Country/Sub-region
  • 7.4.1. U.K.
  • 7.4.2. Germany
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis - By Type
  • 8.2.1. Lithotripsy
  • 8.2.2. Ureteroscopy
  • 8.2.3. Percutaneous Nephrolithonomy (PCNL)
• 8.3. Market Analysis - By End User
  • 8.3.1. Hospitals
  • 8.3.2. Specialty Clinics
  • 8.3.3. Ambulatory Surgical Centers
• 8.4. Market Analysis - By Country/Sub-region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis - By Type
  • 9.2.1. Lithotripsy
  • 9.2.2. Ureteroscopy
  • 9.2.3. Percutaneous Nephrolithonomy (PCNL)
• 9.3. Market Analysis - By End User
  • 9.3.1. Hospitals
  • 9.3.2. Specialty Clinics
  • 9.3.3. Ambulatory Surgical Centers
• 9.4. Market Analysis - By Country/Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Kidney Stone Management Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis - By Type
  • 10.2.1. Lithotripsy
  • 10.2.2. Ureteroscopy
  • 10.2.3. Percutaneous Nephrolithonomy (PCNL)
• 10.3. Market Analysis - By End User
  • 10.3.1. Hospitals
  • 10.3.2. Specialty Clinics
  • 10.3.3. Ambulatory Surgical Centers
• 10.4. Market Analysis - By Country/Sub-region
  • 10.4.1. GCC Countries
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2021)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles (Overview, Products & Services, SWOT analysis, Recent developments, Strategies, Financials (based on availability))
  • 11.5.1. Cook Medical Inc.
    • 11.5.1.1. Overview,
    • 11.5.1.2. Products & Services,
    • 11.5.1.3. SWOT analysis,
    • 11.5.1.4. Recent developments,
    • 11.5.1.5. Strategies,
    • 11.5.1.6. Financials (based on availability)
  • 11.5.2. Olympus Corp.
    • 11.5.2.1. Overview,
    • 11.5.2.2. Products & Services,
    • 11.5.2.3. SWOT analysis,
    • 11.5.2.4. Recent developments,
    • 11.5.2.5. Strategies,
    • 11.5.2.6. Financials (based on availability)
  • 11.5.3. C.R. Bard Inc.
    • 11.5.3.1. Overview,
    • 11.5.3.2. Products & Services,
    • 11.5.3.3. SWOT analysis,
    • 11.5.3.4. Recent developments,
    • 11.5.3.5. Strategies,
    • 11.5.3.6. Financials (based on availability)
  • 11.5.4. Boston Scientific Corporation
    • 11.5.4.1. Overview,
    • 11.5.4.2. Products & Services,
    • 11.5.4.3. SWOT analysis,
    • 11.5.4.4. Recent developments,
    • 11.5.4.5. Strategies,
    • 11.5.4.6. Financials (based on availability)
  • 11.5.5. STORZ MEDICAL AG
    • 11.5.5.1. Overview,
    • 11.5.5.2. Products & Services,
    • 11.5.5.3. SWOT analysis,
    • 11.5.5.4. Recent developments,
    • 11.5.5.5. Strategies,
    • 11.5.5.6. Financials (based on availability)
  • 11.5.6. Richard Wolf GmbH
    • 11.5.6.1. Overview,
    • 11.5.6.2. Products & Services,
    • 11.5.6.3. SWOT analysis,
    • 11.5.6.4. Recent developments,
    • 11.5.6.5. Strategies,
    • 11.5.6.6. Financials (based on availability)
  • 11.5.7. Lumenis
    • 11.5.7.1. Overview,
    • 11.5.7.2. Products & Services,
    • 11.5.7.3. SWOT analysis,
    • 11.5.7.4. Recent developments,
    • 11.5.7.5. Strategies,
    • 11.5.7.6. Financials (based on availability)
  • 11.5.8. EDAP TMS
    • 11.5.8.1. Overview,
    • 11.5.8.2. Products & Services,
    • 11.5.8.3. SWOT analysis,
    • 11.5.8.4. Recent developments,
    • 11.5.8.5. Strategies,
    • 11.5.8.6. Financials (based on availability)
  • 11.5.9. DirexGroup
    • 11.5.9.1. Overview,
    • 11.5.9.2. Products & Services,
    • 11.5.9.3. SWOT analysis,
    • 11.5.9.4. Recent developments,
    • 11.5.9.5. Strategies,
    • 11.5.9.6. Financials (based on availability)
  • 11.5.10. Other prominent players
    • 11.5.10.1. Overview,
    • 11.5.10.2. Products & Services,
    • 11.5.10.3. SWOT analysis,
    • 11.5.10.4. Recent developments,
    • 11.5.10.5. Strategies,
    • 11.5.10.6. Financials (based on availability)

12. Strategic Recommendations